Rubicon Research Limited (RUBICON) — Announcement

· NSE Neutral

Rubicon Research Limited announced its quarterly earnings conference call scheduled for May 29, 2026, to review financial results for the quarter and year ended March 31, 2026, and discuss future outlook. The call will feature senior management presentations and a Q&A session, providing investors direct insight into performance and strategy.

📄 View Original Announcement (PDF)

About Rubicon Research Limited (RUBICON)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,864.53 Cr

View full RUBICON stock details →

📡 Get AI alerts when RUBICON files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RUBICON — Free

📊 More RUBICON filings

See all RUBICON filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when RUBICON files new disclosures

Track RUBICON filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RUBICON — Free

Free account · 2 AI queries/day